US Retail Sales Data Indicates Consumer Resilience Amid Persistent Cost Pressures Healthcare Technology Poised to Transform Patient Outcomes and Clinical Practices NASA Taps Blue Origin for First Lunar Mission in 20B Moon Base Plan Drama Desk Awards Reshape Tony Awards Race Offering Potential Market Signals for Broadway Productions Louisiana Senators Land Sale Near Meta Datacenter Raises Ethics Questions Police to Score UK Train Operators on Sexual Harassment Prevention No Financial Penalties for Missing Targets Burford Capital Q1 2026 Earnings Massive EPS Miss as Litigation Outcomes Weigh WHG Q1 2026 Earnings Earnings Per Share of 031 Amid Mixed Market Conditions AIZ Q1 2026 Earnings EPS Surges 113 Above Estimates Stock Edges Lower HNVR Q1 2026 Earnings Slight EPS Miss Masks Underlying Stability LW Q1 2026 Earnings EPS Beats Estimates by 14 Shares Slide Despite Strong Profit Performance Lyell Immunopharma Q1 2026 Earnings Narrower Loss Beats Estimates as Pipeline Progress Continues Gorilla Technology Warrant GRRRW Retreats Toward Support Amid Thin Trading Black Spade Acquisition III BIII Holds Steady Near 10 as SPAC Awaits Business Combination Immatics IMTX Gains Ground Biotech Stock Tests Key Resistance at 1196 EZGO Technologies EZGO Shares Slide 926 as Stock Tests Key Support at 140 Granite Construction GVA Gains 23 as Infrastructure Momentum Builds The Mandalorian and Grogu Poised to Revitalize Star Wars Franchise for Disney Milestone Pharmaceuticals MIST Q1 2026 Earnings EPS Miss Deepens as ClinicalStage Biotech Navigates Development Path OR Royalties Inc OR Slips 33 as Price Tests Key Support Levels IINN Q4 2023 Earnings Narrower Loss Surprises as Inspira Advances Clinical Milestones CECO Environmental Corp Q1 2026 Earnings Massive EPS Beat of 1395 Surprise CACC Q1 2026 Earnings EPS Slightly Misses Estimates Amid Steady Operations REZI Q1 2026 Earnings EPS Beats Estimates Despite Modest Stock Decline BAER Q1 2026 Earnings EPS Miss of 537 with Uptick in Stock Price Evommune Inc EVMN Q1 2026 Earnings EPS Beats Estimates as PreRevenue Biotech Focuses on Pipeline Progress ADT Inc Q1 2026 Earnings EPS Beat Bolsters Margins Despite Revenue Discreetness